United Therapeutics (UTHR) Tops Q1 EPS by 89c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. REGN
2. LITE
3. CRWD
4. AAPL
5. MRVL
6. ABBV
7. CL
8. TFII
9. ORCL
10. PLTR

Go back to United Therapeutics (UTHR) Tops Q1 EPS by 89c, Revenues Beat

United Therapeutics Corporation Reports First Quarter 2020 Financial Results

April 29, 2020 6:00 AM EDT

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 29, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the quarter ended March 31, 2020. First quarter net revenue decreased 2% to $356.3 million year-over-year while first quarter net revenue excluding Adcirca increased 0.4%, compared to the first quarter of 2019. First quarter diluted earnings per share (EPS) was $3.12 compared to an $11.32 per share loss in the first quarter of 2019. Non-GAAP diluted EPS of $3.61 was up 1% from the first quarter of 2019.

"I'm proud of the efforts of the entire United Therapeutics team... More